Chameleon Biosciences
Berkeley, US · Founded 2017 · Delaware corporation · 4 known investors
Founders & leadership
Chameleon Biosciences was founded in 2017 by Genine A. Winslow and Genine Winslow.
GA
Genine A. WinslowCo-founder
GW
Genine WinslowinFounder
RG
Ran GengNamed on SEC filing
WW
Winnie WanNamed on SEC filing
Investors · 4
Reported raises · per SEC filings
Form D private placements$10.6M disclosed across 1 round · 2021
▶$10.6MraisedMar 2021 · 23 investors · BiotechnologyRule 506(b)
▶$10.6MraisedMar 2021 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ran GengDirector
- Winnie WanDirector
- Genine A. WinslowExecutive Officer, Director
- Offering amount
- $23M
- Amount sold
- $10.6M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Chameleon Biosciences?
- Chameleon Biosciences was founded by Genine A. Winslow, Genine Winslow in 2017.
- Who are Chameleon Biosciences's investors?
- Chameleon Biosciences's investors include Berkeley SkyDeck Fund, Future Planet Capital, Solasta Ventures, Tachyon Ventures.
- How much funding has Chameleon Biosciences raised?
- Chameleon Biosciences has disclosed $10.6M raised across 1 round.
- Where is Chameleon Biosciences headquartered?
- Chameleon Biosciences is headquartered in Berkeley, US.